Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

56
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
56
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

45
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
45
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

47
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
47
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

50
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
50
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

39
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
39
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

63
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
63

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Word of Caution: Aorto-Right Ventricular Fistula, an Uncommon Pitfall of Perceval Sutureless Valve.

Journal of cardiovascular development and disease·2026
Same author

Diagnostic and prognostic relevance of valve strands in patients with suspected infective endocarditis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Low-dose levosimendan infusions in advanced heart failure: efficacy, safety, and factors associated with outcomes.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Mind the Gap: Inadequate Performance of Embolic Risk Scores in Infective Endocarditis.

Open forum infectious diseases·2026
Same author

An Elegant Approach for Complete Revascularization of the Circumflex Territory.

Reports (MDPI)·2026
Same author

First-in-Human Intramediastinal Taurolidine Irrigation for <i>Candida albicans</i> Mediastinitis After Biological Bentall Procedure.

Journal of cardiovascular development and disease·2026

Related Experiment Video

Updated: Oct 3, 2025

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.6K

Cardiac Surgery in Advanced Heart Failure.

Roger Hullin1, Philippe Meyer2, Patrick Yerly1

  • 1Cardiology, Cardiovascular Department, University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland.

Journal of Clinical Medicine
|February 15, 2022
PubMed
Summary

Mechanical circulatory support and heart transplantation are key treatments for advanced heart failure. This review covers recent surgical advances and offers a treatment algorithm for older patients (>65 years).

Keywords:
cardiac surgeryend-stage heart failureoutcome

More Related Videos

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.5K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.8K

Related Experiment Videos

Last Updated: Oct 3, 2025

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.6K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.5K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.8K

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Geriatric Medicine

Background:

  • Advanced heart failure (AHF) prevalence is increasing globally.
  • Mechanical circulatory support (MCS) and heart transplantation (HTx) are established AHF treatments.
  • There is a growing need for effective AHF management strategies.

Purpose of the Study:

  • To review recent advancements in surgical treatment options for AHF.
  • To propose a treatment algorithm for AHF patients over 65 years of age.
  • To address the rising demand for MCS and HTx.

Main Methods:

  • Narrative review of current literature on AHF surgical treatments.
  • Analysis of recent progress in MCS and HTx technologies and outcomes.
  • Development of a clinical decision-making algorithm for elderly AHF patients.

Main Results:

  • Recent innovations have expanded the utility and improved outcomes of MCS devices.
  • Heart transplantation remains a viable option for select AHF patients.
  • The proposed algorithm stratifies treatment based on patient age, comorbidities, and disease severity.

Conclusions:

  • Surgical interventions, including MCS and HTx, are crucial for managing AHF.
  • An age-tailored approach is necessary for optimizing treatment in elderly AHF patients.
  • Further research is needed to refine treatment strategies for the growing AHF population.